Rede von Georg Waltemath gegen die Antisemiten : geh. am 1. Sept. 1891 in d. Versammlung d. Hamburger Vereins d. Deutschen Freisinnigen Partei

Georg Waltemath. Hrsg. vom Vorstand d. Vereins

Wie müssen wir uns als Christen gegen die Juden verhalten? Predigt geh. in Copenhagen 1789 ... über das Evangelium Matth. 24, 15-28

von [Balthasar] Münter

L' Alsace juive depuis la révolution de 1789 : Conférence faite à Colmar le 27 mars 1907

par Maurice Bloch

Gli Israeliti d'Europa nella civiltà : memorie storiche, biografiche e statistiche dal 1789 al 1870

per Flaminio Servi

De la Condition politique et civile des juifs dans le Royaume de Pologne : examen critique d'un rapport adressé en l'année 1858 à l'Empereur Alexandre II, par le départememt de l'intérieur et des cultes du Royaume de Pologne ; texte précédé et suivi d'observations historiques, politiques et législatives

par Louis Lubliner

La condition des Juifs en France depuis 1789

par Henry Lucien-Brun

Electrolyte disorders and in-hospital mortality during prolonged heat periods: a cross-sectional analysis

BACKGROUND Heat periods during recent years were associated with excess hospitalization and mortality rates, especially in the elderly. We intended to study whether prolonged warmth/heat periods are associated with an increased prevalence of disorders of serum sodium and potassium and an increased hospital mortality. METHODS In this cross-sectional analysis all patients admitted to the Department of Emergency Medicine of a large tertiary care facility between January 2009 and December 2010 with measurements of serum sodium were included. Demographic data along with detailed data on diuretic medication, length of hospital stay and hospital mortality were obtained for all patients. Data on daily temperatures (maximum, mean, minimum) and humidity were retrieved by Meteo Swiss. RESULTS A total of 22.239 patients were included in the study. 5 periods with a temperature exceeding 25 °C for 3 to 5 days were noticed and 2 periods with temperatures exceeding 25 °C for more than 5 days were noted. Additionally, 2 periods with 3 to 5 days with daily temperatures exceeding 30 °C were noted during the study period. We found a significantly increased prevalence of hyponatremia during heat periods. However, in the Cox regression analysis, prolonged heat was not associated with the prevalence of disorders of serum sodium or potassium. Admission during a heat period was an independent predictor for hospital mortality. CONCLUSIONS Although we found an increased prevalence of hyponatremia during heat periods, no convincing connection could be found for hypernatremia or disorders of serum potassium.

Jüdische Charakterbilder : enthaltend die ausführlichen Biografien von Rabbi Jonathan Eibenschütz, Rabbi Akiba Eger, Rabbi Markus Benedikt ...

hrsg. von M. Ehrentheil

Bar-Mitzwa : 13e anniversaire d'Edmond Baron de Rothschild célébré au Grand Temple Israélite de Paris le samedi 24 Tischri 5619 (2. oct. 1858)

[Verf.: Léon Hollaénderski]

Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level:: The Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study.

BACKGROUND Rivaroxaban has become an alternative to vitamin-K antagonists (VKA) for stroke prevention in non-valvular atrial fibrillation (AF) patients due to its favourable risk-benefit profile in the restrictive setting of a large randomized trial. However in the primary care setting, physician's motivation to begin with rivaroxaban, treatment satisfaction and the clinical event rate after the initiation of rivaroxaban are not known. METHODS Prospective data collection by 115 primary care physicians in Switzerland on consecutive nonvalvular AF patients with newly established rivaroxaban anticoagulation with 3-month follow-up. RESULTS We enrolled 537 patients (73±11years, 57% men) with mean CHADS2 and HAS-BLED-scores of 2.2±1.3 and 2.4±1.1, respectively: 301(56%) were switched from VKA to rivaroxaban (STR-group) and 236(44%) were VKA-naïve (VN-group). Absence of routine coagulation monitoring (68%) and fixed-dose once-daily treatment (58%) were the most frequent criteria for physicians to initiate rivaroxaban. In the STR-group, patient's satisfaction increased from 3.6±1.4 under VKA to 5.5±0.8 points (P<0.001), and overall physician satisfaction from 3.9±1.3 to 5.4±0.9 points (P<0.001) at 3months of rivaroxaban therapy (score from 1 to 6 with higher scores indicating greater satisfaction). In the VN-group, both patient's (5.4±0.9) and physician's satisfaction (5.5±0.7) at follow-up were comparable to the STR-group. During follow-up, 1(0.19%; 95%CI, 0.01-1.03%) ischemic stroke, 2(0.37%; 95%CI, 0.05-1.34%) major non-fatal bleeding and 11(2.05%; 95%CI, 1.03-3.64%) minor bleeding complications occurred. Rivaroxaban was stopped in 30(5.6%) patients, with side effects being the most frequent reason. CONCLUSION Initiation of rivaroxaban for patients with nonvalvular AF by primary care physicians was associated with a low clinical event rate and with high overall patient's and physician's satisfaction.

Georg Herwegh und die literarische Zeitung

Edgar Bauer